Ferrous Sulfate Oral Pediatric Drops
Last Updated: January 31, 2017
Products Affected - Description
All presentations are currently available
Reason for the Shortage
Several liquid products were affected by a recall from PharmaTech due to potential contamination from B. cepacia. These included the ferrous sulfate liquid products from Akorn and Major. FDA issued a MedWatch report with the products affected.
Enfamil Fer-In-Sol oral drops, Mead-Johnson
15 mg/mL, 50 mL bottle, 1 count (NDC 00087-0740-02)
15 mg/mL, 50 mL bottle, 1 count (NDC 00536-0710-80)
15 mg/mL, 50 mL bottle, 1 count (NDC 39328-0057-50)
15 mg/mL, 50 mL bottle, 1 count (NDC 50383-0627-50)
15 mg/mL, 50 mL bottle, 1 count (NDC 00904-6060-50)
Estimated Resupply Dates
All presentations are available.
- Iron Dextran Injection — Resolved
- Iron Polysaccharide Oral Liquid — No Longer Available
- Iron Sucrose Injection — Resolved
January 31 and 9, 2017; November 1, September 27, August 11, 2016, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.